Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|March 1, 2013
Ropack Spring Show Guide
Advertisement
Ropack provides contract packaging and manufacturing services for more than 90 U.S., Canadian and European pharmaceutical and consumer healthcare customers. Flexible, responsive and competitive, we focus on reliably accelerating the go-to-market timeline. Our 250,000 square feet of production, warehousing and distribution space includes a 15,000-square-foot, $9M facility for stick-pack packaging of humidity- and temperature-sensitive products. Because of taste-masking and convenience – without compromising integrity – stick-pack is ideal for uni-dose pediatric powders.
E-mail:
Website:
Shows attending:
- BIO - Quebec Pavilion
- INTERPHEX - booth 1166
- AAPS Biotech - booth 3649
Advertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement